Connexin-based Signaling in the Heart: Cellular and Exosomal

心脏中基于连接蛋白的信号传导:细胞和外泌体

基本信息

  • 批准号:
    10353582
  • 负责人:
  • 金额:
    $ 87.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-20 至 2028-12-31
  • 项目状态:
    未结题

项目摘要

PROJECT ABSTRACT/SUMMARY The gap junction (GJ) protein Connexin 43 (Cx43) has long been held to be obligate for conduction of action potential (AP) in the ventricular myocardium. However, accumulating evidence during the last two decades from non-mammals, Cx43 knockout mice and human Cx43 mutations suggests that Cx43 GJs do not provide a sufficient explanation for how AP propagates in the heart – and indeed, that Cx43 GJs may be dispensable for cardiac conduction. Based on its short half (~1.5 hours), we recently estimated that on average the human female heart produces more than 80 grams of Cx43 per year – a rate more than 30-times that of actin, the most abundant myocardial protein in steady state. My lab is focused on two questions that are raised by these data. First, what is the mechanism of AP propagation in the ventricle, if Cx43 GJ-based coupling alone cannot account for this phenomenon? Second, if not absolutely required for cardiac conduction, for what purpose does the heart produce Cx43 at such high rates? In recently reported studies, we have determined that: A) Trans- interacting complexes of voltage-gated sodium channels (trans-VGSCs) located at the GJ edge (the perinexus) contribute to cardiac conduction; and B) That the Cx43 carboxyl terminus (CT) has key roles in modulating the heart's response to ischemic injury. Building on these findings, the goals of this project are to: 1) Determine the contribution of trans-VGSCs to cardiac AP propagation and the extent to which this mechanism operates independent of Cx43 GJ-based coupling; 2) Develop a pharmacologic approach to targeting trans-VGSCs as a novel anti-arrhythmic strategy; 3) Determine the extent to which the high levels of Cx43 production by the heart may be accounted for by recent findings that Cx43 is exported in exosomes; 4) Determine whether circulating exosomal Cx43, including Cx43 CT isoforms, are part of a natural signaling mechanism that modulates ischemic injury severity; and 5) Develop a novel therapeutic approach to treat myocardial infarction based on exosomes carrying Cx43 CT mimetic peptides, including translational testing in a large animal model – the pig. The project will involve cross-disciplinary collaboration between biologists, medicinal chemists, biomedical engineers and clinicians – both human and veterinary. The PI has genuine translational bona-fides, with a drug targeting the Cx43 CT invented in his lab currently in multiple Phase III clinical trials. State-of-the-art approaches will be used including super resolution imaging, in silico drug design, genetically modified viruses, iPSCs and testing of exosome-based therapeutics on large animal models. We posit that the primary assignment of myocardial Cx43 may not be in AP propagation. Rather, it is our hypothesis that the high energetic commitment to Cx43 production made by the heart, and other tissues (e.g., skin, vasculature and brain), relates mainly to functions of Cx43 in an exosome-based signaling mechanism that modulates response to ischemic injury in humans and other mammals. This R35 project seeks to challenge prevailing views on the role of the GJ protein Cx43 and translate the new perspectives gained for clinical benefit in treatment of arrhythmia and myocardial infarction.
项目摘要/摘要 缝隙连接(GJ)蛋白连接蛋白43(Cx43)长期以来一直被认为是动作传导的必备蛋白 心室肌的电位(AP)。然而,在过去20年里积累的证据表明 非哺乳动物、Cx43基因敲除小鼠和人类Cx43突变表明Cx43 GJS不提供 对AP如何在心脏传播的充分解释-实际上,Cx43 GJS对于 心脏传导。根据它的短短半小时(~1.5小时),我们最近估计,平均而言,人类女性 心脏每年产生超过80克的Cx43--这个速度是肌动蛋白的30倍以上,肌动蛋白是最丰富的 心肌蛋白质处于稳定状态。我的实验室专注于这些数据提出的两个问题。第一, 如果仅基于Cx43 GJ的偶联不能解释,AP在脑室的传播机制是什么 这种现象?第二,如果心脏传导不是绝对需要的,心脏有什么目的? 以如此高的速度生产Cx43?在最近报道的研究中,我们确定:a)反式- 电压门控钠通道相互作用复合体(TRANS-VGSCs)位于GJ边缘(周围神经节) 有助于心脏传导;以及B)Cx43羧基末端(CT)在调节 心脏对缺血损伤的反应。基于这些发现,该项目的目标是:1)确定 反式VGSCs在心脏AP传播中的作用及其作用程度 独立于基于Cx43 GJ的偶联;2)开发一种以反式VGSC为靶点的药理学方法 新的抗心律失常策略;3)确定心脏高水平产生Cx43的程度 这可能是因为最近的研究发现,Cx43在外切体中输出;4)确定循环 胞外体Cx43,包括Cx43 CT亚型,是调节缺血的自然信号机制的一部分 损伤严重程度;以及5)开发基于外切体的治疗心肌梗死的新方法 携带Cx43 CT模拟多肽,包括在大型动物模型-猪身上进行翻译测试。该项目 将涉及生物学家、药物化学家、生物医学工程师和 临床医生--包括人类和兽医。PI有真正的翻译诚意,有一种药物针对 Cx43 CT是在他的实验室发明的,目前正在进行多个第三阶段临床试验。将使用最先进的方法 包括超分辨率成像,在硅胶药物设计,转基因病毒,ipscs和测试 在大型动物模型上的基于外显子的疗法。我们假设心肌细胞Cx43的初步定位 可能不在AP传播中。相反,我们的假设是,对Cx43的高能承诺 由心脏和其他组织(如皮肤、血管和大脑)产生的物质主要与 Cx43在基于外体的信号机制中的作用,该机制调节人类和其他动物对缺血性损伤的反应 哺乳动物。这个R35项目试图挑战关于GJ蛋白Cx43作用的主流观点,并翻译 为临床治疗心律失常和心肌梗死提供了新的视角。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT G GOURDIE其他文献

ROBERT G GOURDIE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT G GOURDIE', 18)}}的其他基金

Connexin-based Signaling in the Heart: Cellular and Exosomal
心脏中基于连接蛋白的信号传导:细胞和外泌体
  • 批准号:
    10553255
  • 财政年份:
    2022
  • 资助金额:
    $ 87.5万
  • 项目类别:
The Role of the Sodium Channel Beta Subunit in Cardiac Conduction
钠通道β亚基在心脏传导中的作用
  • 批准号:
    9923757
  • 财政年份:
    2018
  • 资助金额:
    $ 87.5万
  • 项目类别:
International Gap Junction Conference 2013
2013年国际间隙连接会议
  • 批准号:
    8529886
  • 财政年份:
    2013
  • 资助金额:
    $ 87.5万
  • 项目类别:
Gap Junctional Patterning in Arrhythmic Heart
心律失常心脏的间隙连接模式
  • 批准号:
    8227961
  • 财政年份:
    2010
  • 资助金额:
    $ 87.5万
  • 项目类别:
MECHANISMS THAT MODULATE GAP JUNCTION SIZE, DISTRIBUTION AND TURNOVER
调节间隙连接尺寸、分布和周转的机制
  • 批准号:
    8169609
  • 财政年份:
    2010
  • 资助金额:
    $ 87.5万
  • 项目类别:
Gap Junctional Patterning in Arrhythmic Heart
心律失常心脏的间隙连接模式
  • 批准号:
    8438508
  • 财政年份:
    2010
  • 资助金额:
    $ 87.5万
  • 项目类别:
Gap Junctional Patterning in Arrhythmic Heart
心律失常心脏的间隙连接模式
  • 批准号:
    8049732
  • 财政年份:
    2010
  • 资助金额:
    $ 87.5万
  • 项目类别:
Gap Junctional Patterning in Arrhythmic Heart
心律失常心脏的间隙连接模式
  • 批准号:
    7783508
  • 财政年份:
    2010
  • 资助金额:
    $ 87.5万
  • 项目类别:
MECHANISMS THAT MODULATE GAP JUNCTION SIZE, DISTRIBUTION AND TURNOVER
调节间隙连接尺寸、分布和周转的机制
  • 批准号:
    7957617
  • 财政年份:
    2009
  • 资助金额:
    $ 87.5万
  • 项目类别:
MECHANISMS THAT MODULATE GAP JUNCTION SIZE, DISTRIBUTION AND TURNOVER
调节间隙连接尺寸、分布和周转的机制
  • 批准号:
    7722440
  • 财政年份:
    2008
  • 资助金额:
    $ 87.5万
  • 项目类别:

相似海外基金

Kilohertz volumetric imaging of neuronal action potentials in awake behaving mice
清醒行为小鼠神经元动作电位的千赫兹体积成像
  • 批准号:
    10515267
  • 财政年份:
    2022
  • 资助金额:
    $ 87.5万
  • 项目类别:
Signal processing in horizontal cells of the mammalian retina – coding of visual information by calcium and sodium action potentials
哺乳动物视网膜水平细胞的信号处理 â 通过钙和钠动作电位编码视觉信息
  • 批准号:
    422915148
  • 财政年份:
    2019
  • 资助金额:
    $ 87.5万
  • 项目类别:
    Research Grants
CAREER: Resolving action potentials and high-density neural signals from the surface of the brain
职业:解析来自大脑表面的动作电位和高密度神经信号
  • 批准号:
    1752274
  • 财政年份:
    2018
  • 资助金额:
    $ 87.5万
  • 项目类别:
    Continuing Grant
Development of Nanosheet-Based Wireless Probes for Multi-Simultaneous Monitoring of Action Potentials and Neurotransmitters
开发基于纳米片的无线探针,用于同时监测动作电位和神经递质
  • 批准号:
    18H03539
  • 财政年份:
    2018
  • 资助金额:
    $ 87.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Population Imaging of Action Potentials by Novel Two-Photon Microscopes and Genetically Encoded Voltage Indicators
通过新型双光子显微镜和基因编码电压指示器对动作电位进行群体成像
  • 批准号:
    9588470
  • 财政年份:
    2018
  • 资助金额:
    $ 87.5万
  • 项目类别:
Enhanced quantitative imaging of compound action potentials in multi-fascicular peripheral nerve with fast neural Electrical Impedance Tomography enabled by 3D multi-plane softening bioelectronics
通过 3D 多平面软化生物电子学实现快速神经电阻抗断层扫描,增强多束周围神经复合动作电位的定量成像
  • 批准号:
    10009724
  • 财政年份:
    2018
  • 资助金额:
    $ 87.5万
  • 项目类别:
Enhanced quantitative imaging of compound action potentials in multi-fascicular peripheral nerve with fast neural Electrical Impedance Tomography enabled by 3D multi-plane softening bioelectronics
通过 3D 多平面软化生物电子学实现快速神经电阻抗断层扫描,增强多束周围神经复合动作电位的定量成像
  • 批准号:
    10467225
  • 财政年份:
    2018
  • 资助金额:
    $ 87.5万
  • 项目类别:
Fast high-resolution deep photoacoustic tomography of action potentials in brains
大脑动作电位的快速高分辨率深度光声断层扫描
  • 批准号:
    9423398
  • 财政年份:
    2017
  • 资助金额:
    $ 87.5万
  • 项目类别:
NeuroGrid: a scalable system for large-scale recording of action potentials from the brain surface
NeuroGrid:用于大规模记录大脑表面动作电位的可扩展系统
  • 批准号:
    9357409
  • 财政年份:
    2016
  • 资助金额:
    $ 87.5万
  • 项目类别:
Noval regulatory mechanisms of axonal action potentials
轴突动作电位的新调节机制
  • 批准号:
    16K07006
  • 财政年份:
    2016
  • 资助金额:
    $ 87.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了